Deel: 17.3 billion dollars, 1.5 billion of recurring revenue, and litigation that has survived dismissal

By Unicorn Private Research. Published and last updated 26 September 2026.

Key takeaways

The Series E closed on 20 October 2025 at 17.3 billion dollars, raising 300 million, co-led by Ribbit Capital and Andreessen Horowitz with Coatue.
The company reported crossing 1 billion dollars of annual recurring revenue in 2025 and 1.5 billion in the first half of 2026, with about 22 billion dollars of payroll processed a year.
Rippling's claims against Deel for racketeering and trade secret misappropriation survived a motion to dismiss on 23 February 2026 and are in discovery. No court has ruled on the merits.
The Wall Street Journal reported in January 2026 that federal prosecutors issued grand jury subpoenas in the matter. No charges have been reported.

Deel is a fast-growing business with a serious legal overhang, and the two facts have to be held together. Treating the litigation as noise is a mistake, because it has already cleared the stage at which weak claims are dismissed. Treating it as a verdict is equally a mistake, because no court has found anything on the merits.

The commercial record

Figure	What it is	Source and date
17.3 billion dollars	Series E valuation, 300 million dollars raised	Deel, 20 October 2025
Over 12 billion dollars	Secondary transaction, proceeds to selling early investors	February 2025
Over 1 billion dollars	Annual recurring revenue, with a first 100 million dollar month in September 2025	Deel, 20 October 2025
1.5 billion dollars	Annual recurring revenue in the first half of 2026	CTech, 3 August 2026

The company also reports about 22 billion dollars of payroll processed annually and over 40,000 businesses on the platform. Revenue growth of that order at that scale is genuinely unusual, and it is the reason the name is in the index at all.

The litigation, stated precisely

Rippling sued Deel in the United States District Court for the Northern District of California on 17 March 2025. Rippling alleges that Deel cultivated an employee in Rippling's Dublin office to take sales and customer information. Deel denies wrongdoing and countersued in Delaware on 25 April 2025, alleging that Rippling placed its own insider at Deel and that a Rippling employee accessed Deel's platform under a false company name. Each of those is an allegation by the party making it.

What has actually happened in court, as distinct from what each side says:

On 2 April 2025 a former Rippling employee filed a sworn affidavit in Ireland's High Court admitting he took information for Deel. That is his sworn statement, not a judicial finding against Deel, and Deel has sought to strike his testimony.
On 23 February 2026 Judge Breyer denied Deel's motion to dismiss on racketeering, racketeering conspiracy, trade secret misappropriation, tortious interference and aiding and abetting breach of fiduciary duty, while dismissing part of a California unfair competition claim. That is a pleadings ruling: it holds the claims were adequately stated, not that they are true.
On 26 September 2026 the court refused to strike the former employee's testimony and sent Deel's most serious counterclaims to private arbitration, while dismissing certain other Deel claims.
No court has found that Deel ran a spy, that any executive directed anything, or that Rippling infiltrated Deel. There is no damages award and no verdict.

Separately, the Wall Street Journal reported in January 2026 that the United States Attorney for the Northern District of California issued grand jury subpoenas seeking information about the alleged plot. Deel said it was not aware of a criminal investigation and would cooperate. No charges have been reported.

What a buyer is taking on before a listing

Litigation that has passed the dismissal stage and entered discovery, with an unquantified range of outcomes.
A reported criminal inquiry with no charges, which is an overhang rather than a liability.
A secondary price that has shown no premium to the last round, quoted at the same level as the October 2025 price nearly a year later.
Regulatory complexity inherent in running payroll and employer-of-record services across many jurisdictions.
Transfer restrictions and rights of first refusal that must be cleared before any purchase completes.

Exposure before a listing

No filing has been verified, and the company has spoken publicly about listing without committing to timing. Access is through the secondary market with the company's consent. Unicorn Private buys secondary positions in established companies with real revenue, and Deel plainly qualifies on the business. The work on this name is the legal file: an investor should read the actual orders rather than either side's description of them, which is why they are linked in full below.

The short answer

Deel is valued at 17.3 billion dollars on an October 2025 round, with 1.5 billion dollars of recurring revenue reported in 2026. Its defence of Rippling's racketeering and trade secret claims failed to get them dismissed, so the case is in discovery, and prosecutors have reportedly issued subpoenas. Nothing has been decided on the merits, and that uncertainty is the position.

Related guides

About the publisher

This guide is published by Unicorn Private Research, the research arm of Unicorn Private LLC, a Delaware private equity firm that acquires secondary stakes in late-stage private technology companies before their IPO. The firm invests only in established companies already valued above one billion dollars, not in early-stage start-ups, and its founders have been active in private equity and startup investing since 2005.

Unicorn Private is the first firm in the pre-IPO secondary market to create an open and entirely free research centre in nine languages: guides, a tracker of the largest private technology companies, a glossary, and a frequently asked questions section, free to read at no cost, with every figure carrying a date and a link to a public source.

More about Unicorn Private and how it invests